The upcoming initial public offering (IPO) of Indegene Limited, scheduled to commence on May 6, 2024, aims to raise approximately Rs 1,841.76 crores. Established in 1998, Indegene Limited provides digital solutions tailored for the life sciences sector, assisting in various facets such as drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
Prospective investors will have the opportunity to participate in the IPO within a price band ranging from Rs 430 to Rs 452 per share. For individual investors, the minimum lot size required for an application is 33 shares, necessitating a minimum investment of Rs 14,916. Small Individual Investors (sNII) are required to invest in a minimum of 14 lots (462 shares), totaling Rs 2,08,824, while Big Individual Investors (bNII) must commit to a minimum of 68 lots (2,244 shares), amounting to Rs 10,14,288.
Here are ten key points to consider regarding the IPO of Indegene Limited:
1. Subscription Period: The subscription window for the IPO opens on May 6 and closes on May 8, 2024.
2. Price Band: The IPO price range is set at Rs 430 to Rs 452 per equity share.
3. Fundraising Target: Indegene Limited aims to raise Rs 1,841.76 crores through this IPO, with a combination of a fresh issue of 1.68 crore shares and an offer for sale of 2.39 crore shares.
4. Issue Division: The IPO comprises a new issue of 1,68,14,159 shares worth Rs 760 crore and an offer for sale of 2,39,32,732 shares, totaling Rs 1,081.76 crore.
5. Lot Size: Individual investors can apply for the IPO in lots, with each lot containing 33 company shares.
6. Allotment Date: Share allocation finalization is anticipated on May 9, 2024.
7. Listing Date: Indegene Limited shares are scheduled to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on May 13, 2024.
8. Registrar: Link Intime India Private Ltd has been appointed as the registrar for the Indegene Limited IPO.
9. Listing Platforms: The company's shares are proposed to be listed on both BSE and NSE.
10. Grey Market Premium (GMP): As of April 30, 2024, the Grey Market Premium (GMP) for the Indegene IPO stands at Rs 177, indicating an expected listing price of Rs 629 per share, suggesting a potential gain of 39.16% per share.
